Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse

Loco-regional failure after exclusive chemoradiotherapy for esophageal cancer may be due to an inadequately low dose.